Skip to main content
letter
. 2022 Aug 29;68:104153. doi: 10.1016/j.msard.2022.104153

Fig. 1.

Fig. 1

Study design Maccabi Health Services. Source: figure developed based upon information from Schneeweiss et al. (2019), COVID-19, coronavirus disease 2019; MHS, Maccabi Health Services; MS, multiple sclerosis; OCR, ocrelizumab.